Viewing Study NCT05077956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-03-02 @ 4:22 PM
Study NCT ID: NCT05077956
Status: WITHDRAWN
Last Update Posted: 2023-08-07
First Post: 2021-10-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis
Sponsor: Providence Health & Services
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple sclerosis View
None relapsing multiple sclerosis View
None semaphorin 4A View
None sema4a View
None disease modifying therapy View
None biomarker View